423 filings
Page 7 of 22
424B5
oxln2
8 Jan 21
Prospectus supplement for primary offering
5:02pm
424B5
p5znmx37mtye rbrp
7 Jan 21
Prospectus supplement for primary offering
5:07pm
8-K
1v4ldl1
7 Jan 21
Results of Operations and Financial Condition
4:08pm
8-K
lxlzgnly34 xf3
5 Jan 21
Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS
7:06am
8-K
n91uhsv lyjjhw
20 Nov 20
Entry into a Material Definitive Agreement
4:03pm
8-K
c43ry 5izh44
9 Nov 20
Cerecor Reports Third Quarter 2020 Financial Results and Provides Business Update
4:16pm
8-K
g2j4ac1o
13 Oct 20
Cerecor Appoints Gilla Kaplan, Ph.D., to the Board of Directors
6:50am
CT ORDER
pos5nm
9 Sep 20
Confidential treatment order
1:12pm
S-8
ingrzvyqek
6 Aug 20
Registration of securities for employees
4:27pm
8-K
tr9j392dy
6 Aug 20
Cerecor Reports Second Quarter 2020 Financial Results and Business Update
7:10am
8-K
11opjd
18 Jun 20
Departure of Directors or Certain Officers
4:04pm
424B5
02pm7 9pa805hpd
9 Jun 20
Prospectus supplement for primary offering
5:22pm
8-K
sajrzlao
9 Jun 20
Cerecor Inc. Announces Proposed Public Offering of Common Stock
5:18pm
424B5
bfbdt0e5bqi0 lnd
8 Jun 20
Prospectus supplement for primary offering
4:03pm
8-K
ghedo8l5j
1 Jun 20
Results of Operations and Financial Condition
4:44pm
8-K
yl3k5r72 yibpx59eszo
28 May 20
Cerecor Announces FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS
7:04am
8-K
3ix0q73rru48
26 May 20
Other Events
7:12am
EFFECT
rldf1jm
19 May 20
Notice of effectiveness
12:15am